Pfizer aims to become industry leader in gene therapy with acquisition of Bamboo Therapeutics, Inc.

Pfizer Inc. (NYSE:PFE) has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies for the potential treatment of patients with certain rare diseases related to neuromuscular conditions and those affecting the central nervous system. http://www.worldpharmanews.com/pfizer/3570-pfizer-aims-to-become-industry-leader-in-gene-therapy-with-acquisition-of-bamboo-therapeutics-inc